[Not Available].
作者信息
Groulx Stéphane, Limburg Heather, Doull Marion, Klarenbach Scott, Singh Harminder, Wilson Brenda J, Thombs Brett
机构信息
Département de sciences de la santé communautaire (Groulx), Université de Sherbrooke, Sherbrooke, Qué; Agence de la santé publique du Canada (Limburg, Doull), Ottawa, Ont.; Département de médecine (Klarenbach), Université de l'Alberta, Edmonton, Alta.; Médecine interne et sciences de la santé communautaire (Singh), Université du Manitoba, Winnipeg, Man.; Santé communautaire et humanités (Wilson), Université Memorial, St. John's, T.-N.-L.; Département de psychiatrie (Thombs), Hôpital général juif et Université McGill, Montréal, Qué.
出版信息
CMAJ. 2020 Nov 23;192(47):E1597-E1607. doi: 10.1503/cmaj.190814-f.
Abstract
摘要
相似文献
1
[Not Available].[无可用内容]
CMAJ. 2020 Nov 23;192(47):E1597-E1607. doi: 10.1503/cmaj.190814-f.
本文引用的文献
1
Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC).慢性胃食管反流病患者（有或无其他危险因素）的食管腺癌和癌前病变（异型增生和巴雷特食管）筛查：两项系统评价和一项综述评价，为加拿大预防保健特别工作组（CTFPHC）指南提供信息。
Syst Rev. 2020 Jan 29;9(1):20. doi: 10.1186/s13643-020-1275-2.
2
Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer.针对乳腺癌风险未增加的40至74岁女性乳腺癌筛查的建议。
CMAJ. 2018 Dec 10;190(49):E1441-E1451. doi: 10.1503/cmaj.180463.
3
Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.食管腺癌退伍军人中 Barrett 食管筛查和监测的错失机会。
Dig Dis Sci. 2019 Feb;64(2):367-372. doi: 10.1007/s10620-018-5336-5. Epub 2018 Oct 28.
4
Prior Diagnosis of Barrett's Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival.先前诊断出的 Barrett 食管并不常见，但与改善食管腺癌的生存有关。
Dig Dis Sci. 2018 Nov;63(11):3112-3119. doi: 10.1007/s10620-018-5241-y. Epub 2018 Aug 14.
5
Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux.巴雷特食管 3 期临床试验（BEST3）：一项随机对照试验的研究方案，比较 Cytosponge-TFF3 检测与常规护理在初级保健慢性酸反流患者中促进食管前癌诊断的效果。
BMC Cancer. 2018 Aug 3;18(1):784. doi: 10.1186/s12885-018-4664-3.
6
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial.埃索美拉唑和阿司匹林在 Barrett 食管（AspECT）中的应用：一项随机析因试验。
Lancet. 2018 Aug 4;392(10145):400-408. doi: 10.1016/S0140-6736(18)31388-6. Epub 2018 Jul 26.
7
The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.内镜监测对巴雷特食管患者的影响：系统评价和荟萃分析。
Gastroenterology. 2018 Jun;154(8):2068-2086.e5. doi: 10.1053/j.gastro.2018.02.022. Epub 2018 Feb 16.
8
Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus.识别用于 Barrett 食管非内镜检测的 DNA 甲基化生物标志物。
Sci Transl Med. 2018 Jan 17;10(424). doi: 10.1126/scitranslmed.aao5848.
9
Corrigendum: ACG and CAG Clinical Guideline: Management of Dyspepsia.勘误：美国胃肠病学会（ACG）和美国临床肿瘤学会（CAG）消化不良管理临床指南。
Am J Gastroenterol. 2017 Sep;112(9):1484. doi: 10.1038/ajg.2017.238. Epub 2017 Aug 1.
10
The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival.巴雷特食管先前诊断对食管腺癌生存率的影响。
Am J Gastroenterol. 2017 Aug;112(8):1256-1264. doi: 10.1038/ajg.2017.82. Epub 2017 Apr 4.
Zotero 插件